Matteo Pettinari1, Emiliano Navarra2, Philippe Noirhomme2, Herbert Gutermann1. 1. Division of Cardiac Surgery, Ziekenhuis Oost Limburg, Genk, Belgium. 2. Division of Cardiothoracic and Vascular Surgery, St-Luc University Hospital, Catholic University of Louvain, Brussels, Belgium.
Abstract
BACKGROUND: In the past two decades, the introduction of robotic technology has facilitated minimally invasive cardiac surgery, allowing surgeons to operate endoscopically rather than through a median sternotomy. This approach has facilitated procedures for several structural heart conditions, including mitral valve repair, atrial septal defect closure and multivessel minimally invasive coronary artery bypass grafting. In this rapidly evolving field, we review the status of robotic cardiac surgery in Europe with a focus on mitral valve surgery and coronary revascularization. METHODS: Structured searches of MEDLINE, Embase, and Cochrane databases were performed from their dates of inception to June 2016. All original studies, except case-reports, were included in this qualitative review. Studies performed in Europe were presented quantitatively. Data provided from Intuitive Surgical Inc. are also presented. RESULTS: Fourteen papers on coronary surgery were included in the analysis and reported a mortality rate ranging between 0-1%, revision for bleeding between 2-7%, conversion to a larger incision between 2-15%, and patency rate between 92-98%. The number of procedures ranged between 23 and 170 per year. There were only a small number of published reports for robotic mitral valve surgery from European centers. CONCLUSIONS: Coronary robotic surgery in Europe has been performed safely and effectively with very few perioperative complications in the last 15 years. On the other hand, mitral surgery has been developed later with increasing applications of this technology only in the last 5-6 years.
BACKGROUND: In the past two decades, the introduction of robotic technology has facilitated minimally invasive cardiac surgery, allowing surgeons to operate endoscopically rather than through a median sternotomy. This approach has facilitated procedures for several structural heart conditions, including mitral valve repair, atrial septal defect closure and multivessel minimally invasive coronary artery bypass grafting. In this rapidly evolving field, we review the status of robotic cardiac surgery in Europe with a focus on mitral valve surgery and coronary revascularization. METHODS: Structured searches of MEDLINE, Embase, and Cochrane databases were performed from their dates of inception to June 2016. All original studies, except case-reports, were included in this qualitative review. Studies performed in Europe were presented quantitatively. Data provided from Intuitive Surgical Inc. are also presented. RESULTS: Fourteen papers on coronary surgery were included in the analysis and reported a mortality rate ranging between 0-1%, revision for bleeding between 2-7%, conversion to a larger incision between 2-15%, and patency rate between 92-98%. The number of procedures ranged between 23 and 170 per year. There were only a small number of published reports for robotic mitral valve surgery from European centers. CONCLUSIONS: Coronary robotic surgery in Europe has been performed safely and effectively with very few perioperative complications in the last 15 years. On the other hand, mitral surgery has been developed later with increasing applications of this technology only in the last 5-6 years.
Authors: Rakesh M Suri; Amit Taggarse; Harold M Burkhart; Richard C Daly; William Mauermann; Rick A Nishimura; Zhuo Li; Joseph A Dearani; Hector I Michelena; Maurice Enriquez-Sarano Journal: Circulation Date: 2015-10-19 Impact factor: 29.690
Authors: R Scott McClure; Leonidas V Athanasopoulos; Siobhan McGurk; Michael J Davidson; Gregory S Couper; Lawrence H Cohn Journal: J Thorac Cardiovasc Surg Date: 2013-01-23 Impact factor: 5.209
Authors: Jef Van den Eynde; Hannah Vaesen Bentein; Tom Decaluwé; Herbert De Praetere; MaryAnn C Wertan; Francis P Sutter; Husam H Balkhy; Wouter Oosterlinck Journal: J Thorac Dis Date: 2021-07 Impact factor: 2.895
Authors: Stepan Cerny; Wouter Oosterlinck; Burak Onan; Sandeep Singh; Patrique Segers; Cengiz Bolcal; Cem Alhan; Emiliano Navarra; Matteo Pettinari; Frank Van Praet; Herbert De Praetere; Jan Vojacek; Theodor Cebotaru; Paul Modi; Fabien Doguet; Ulrich Franke; Ahmed Ouda; Ludovic Melly; Ghislain Malapert; Louis Labrousse; Monica Gianoli; Alfonso Agnino; Tine Philipsen; Jean-Luc Jansens; Thierry Folliguet; Meindert Palmen; Daniel Pereda; Francesco Musumeci; Piotr Suwalski; Koen Cathenis; Jef Van den Eynde; Johannes Bonatti Journal: Front Cardiovasc Med Date: 2022-01-20